EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $68,779 | -60.6% | 3,538 | -42.5% | 0.00% | -100.0% |
| Q1 2023 | $174,646 | +71476.2% | 6,156 | -26.2% | 0.00% | 0.0% |
| Q4 2022 | $244 | +15.1% | 8,345 | +4.1% | 0.00% | 0.0% |
| Q3 2022 | $212 | -99.9% | 8,017 | +5.1% | 0.00% | -50.0% |
| Q2 2022 | $339,000 | -11.0% | 7,627 | -0.8% | 0.00% | +100.0% |
| Q1 2022 | $381,000 | +6.1% | 7,691 | +9.2% | 0.00% | 0.0% |
| Q4 2021 | $359,000 | -3.2% | 7,046 | +6.1% | 0.00% | 0.0% |
| Q3 2021 | $371,000 | +23.3% | 6,639 | -5.7% | 0.00% | 0.0% |
| Q2 2021 | $301,000 | +2.0% | 7,037 | -0.4% | 0.00% | 0.0% |
| Q1 2021 | $295,000 | -4.8% | 7,064 | +6.1% | 0.00% | 0.0% |
| Q4 2020 | $310,000 | +20.2% | 6,660 | +9.3% | 0.00% | 0.0% |
| Q3 2020 | $258,000 | -11.6% | 6,091 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $292,000 | -3.9% | 6,091 | -7.9% | 0.00% | -50.0% |
| Q1 2020 | $304,000 | -27.4% | 6,615 | -5.1% | 0.00% | 0.0% |
| Q4 2019 | $419,000 | -8.5% | 6,970 | -13.9% | 0.00% | 0.0% |
| Q3 2019 | $458,000 | +9.0% | 8,098 | +7.3% | 0.00% | 0.0% |
| Q2 2019 | $420,000 | +8.0% | 7,546 | -2.0% | 0.00% | 0.0% |
| Q1 2019 | $389,000 | +21.9% | 7,701 | -2.6% | 0.00% | 0.0% |
| Q4 2018 | $319,000 | -23.7% | 7,910 | +31.2% | 0.00% | 0.0% |
| Q3 2018 | $418,000 | -4.3% | 6,031 | +4.4% | 0.00% | 0.0% |
| Q2 2018 | $437,000 | +38.7% | 5,778 | -3.4% | 0.00% | 0.0% |
| Q1 2018 | $315,000 | -7.1% | 5,980 | -5.8% | 0.00% | 0.0% |
| Q4 2017 | $339,000 | -19.3% | 6,349 | -9.8% | 0.00% | 0.0% |
| Q3 2017 | $420,000 | -28.8% | 7,040 | -5.9% | 0.00% | -33.3% |
| Q2 2017 | $590,000 | -5.0% | 7,485 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $621,000 | +23.2% | 7,485 | +17.8% | 0.00% | 0.0% |
| Q4 2016 | $504,000 | +13.3% | 6,355 | 0.0% | 0.00% | +50.0% |
| Q3 2016 | $445,000 | – | 6,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |